ICMR gives nod to antigen-based testing kit for faster diagnosis
Monday, 15 June 2020 The antigen test — developed by private biotechnology firm SD Biosensor — has also been validated by AIIMS, New Delhi, apart from ICMR and can detect presence of SARS CoV 2 in swab collected from the nose alone. Maximum duration for interpreting a positive or negative test is 30 minutes through the antigen based kit.
India on July 14 crossed the 9 lakh mark for coronavirus cases after 28,498 new infections were recorded in the last 24 hours, taking the tally to 9,06,752 which includes 3,11,565 active cases. 5,71,460 people have been recovered from the deadly disease. The death toll has reached 23,727 after 553 COVID related deaths were recorded in the last 24 hours. According to the Indian Council of Medical Research (ICMR), as many as 2,86,247 samples were tested for COVID-19 on July 13, taking the total number of samples tested to over 1.20 crores.
28,701 new COVID-19 cases and 500 deaths were reported in India in the last 24 hours. According to Ministry of Health, total positive cases stand at 8,78,254 including 3,01,609 active cases, 5,53,471 cured/discharged/migrated and 23,174 deaths. According to Indian Council of Medical Research (ICMR), 1,18,06,256 samples have been tested for COVID-19 till July 12, of these 2,19,103 samples were tested yesterday.
India reported 475 deaths and the highest single-day spike of 26,506 new COVID19 cases in the last 24 hours. Positive cases stand at 7,93,802 including 2,76,685 active cases, 4,95,513 cured/discharged/migrated and 21,604 deaths, according to the Ministry of Health and Family Welfare. Total number of samples tested till July 09 is 1,10,24,491 of which 2,83,659 samples were tested yesterday, as per Indian Council of Medical Research.
'Boycott China' facemasks were worn by people in India in protest against China's expansionist policies. In capital New Delhi, a large number of facemasks were distributed in busy market areas to make people aware about boycotting Chinese products as a mark to protest after the Galwan face-off on June 15-16. The Confederation of All India Traders (CAIT), an apex body representing seven crore traders, recently condemned the escalating tensions between the two nations in the border and launched a flagship campaign "Bhartiya Samaan, Hamara Abhimaan" to boycott Chinese goods. The CAIT issued a list of 500 items to be boycotted from categories like FMCG products, consumer durables, toys, finished fabrics, textiles, builder hardware, footwear and apparel among others.
Dead bodies of two patients belonging to two different communities were swapped at All India Institute of Medical Sciences (AIIMS) on July 06. Daughter of the deceased said, "We received a call from AIIMS, and the staff member told us that by mistake they have given someone else's body to us. My mother's body was still in the hospital. The body which we received belonged to a Muslim family." The body of the Muslim woman was cremated following Hindu customs.
A two-person team from the World Health Organization is traveling to China to address the origin of the COVID-19 pandemic. But according to Science Magazine, the epidemiologist and animal health expert are unlikely to come home with answers. The mystery of the virus’ origins has become a political powder keg and the subject of countless conspiracy theories. Chinese officials have reported conducting tests for SARS-CoV-2 at the Wuhan seafood market but what they found remains sketchy.
According to a new study by the team of researchers from Rutgers, asthma does not appear to increase the risk for a person contracting COVID-19 or influence its severity. The recent research was published in the Journal of Allergy and Clinical Immunology. According to Reynold A Panettieri Jr, a pulmonary critical care physician and director of the Rutgers Institute for Translational Medicine and Science and co-author of the paper, Panettieri discusses what we know about asthma and inflammation and the important questions that still need to be answered. Since the news has focused our attention on the effects of COVID-19 on people in vulnerable populations, those with asthma may become hyper-vigilant about personal hygiene and social distancing. Social distancing could improve asthma control since people who are self-quarantined are also not as exposed to seasonal triggers that include allergens or respiratory viruses. There is also evidence that people are being more attentive to taking their asthma medication during the pandemic, which can contribute to overall health. Inhaled corticosteroids, which are commonly used to protect against asthma attacks, also may reduce the ability of the virus to establish an infection. However, studies have shown that steroids may decrease the body's immune response and worsen the inflammatory response. Steroids also have been shown to delay the clearing of the SARS and MERS virus -- similar to SARS-CoV-2- from the respiratory tract and thus may worsen COVID-19 outcomes.Future studies should address whether inhaled steroids in patients with asthma or allergies increase or decrease the risks of SARS-CoV-2 infection and whether these effects are different depending on the steroid type. However, older people with asthma who also have high blood pressure, diabetes or heart disease may have similar instances of COVID-19 as non-asthmatics with those conditions.
Thousands of inmates in California state prisons could be released as early as August. This is in an attempt to curb the spread of covid-19, a frequently deadly disease. The disease itself is caused by the novel coronavirus strain SARS-CoV-2 reports Gizmodo. An estimated 8,000 incarcerated individuals could be released by the end of next month. This measure is meant to create space to allow prisons to better implement safety protocols.
Neurological complications of COVID-19 can include delirium (abrupt change in the brain that causes mental confusion and emotional disruption), brain inflammation, stroke, and nerve damage, a new study has revealed. The study led by the research team at University College London (UCL) and University College London Hospitals (UCLH) was published in the journal Brain. It identified one rare and sometimes fatal inflammatory condition, known as ADEM, which appears to be increasing in prevalence due to the pandemic. Some patients in the study did not experience severe respiratory symptoms, and the neurological disorder was the first and main presentation of COVID-19. The virus causing COVID-19, SARS-CoV-2, was not detected in the cerebrospinal brain fluid of any of the patients tested, suggesting the virus did not directly attack the brain to cause the neurological illness. Further research is needed to identify why patients were developing these complications. In some patients, the researchers found evidence that the brain inflammation was likely caused by an immune response to the disease, suggesting that some neurological complications of COVID-19 might come from the immune response rather than the virus itself.
During Discussion with the faculties of medical colleges, renowned doctors from across the state through a video conference, Rajasthan Chief Minister Ashok Gehlot announced that antigen test will start..